Therapeutic Areas in GI and Hepatology
Ace Therapeutics is dedicated to pioneering innovative solutions in gastroenterology and hepatology research, leveraging our deep therapeutic expertise to provide comprehensive preclinical research services and cutting-edge technical support. By combining advanced disease modeling with multi-omics analytical approaches, we empower researchers to unravel complex disease mechanisms and accelerate the development of transformative therapies for gastrointestinal and hepatic disorders.
Drug Discovery Services
Ace Therapeutics delivers integrated preclinical development services encompassing target validation, and lead optimization studies specifically designed for gastrointestinal and hepatic drug candidates. Our specialized platform combines disease-relevant animal models, advanced biomarker analysis, and safety assessments to accelerate the translation of promising compounds.
Accelerates the development of drug candidates in GI and hepatology.
Develops vaccines against pathogens such as hepatitis viruses and H. pylori.
Designs and optimizes in vitro diagnostic (IVD) materials and assays.
Ace Therapeutics offers an integrated preclinical research platform for liver disease investigation, featuring a diverse collection of validated animal models that faithfully replicate human hepatic pathophysiology.
Ace Therapeutics specializes in preclinical gastroenterology and hepatology research. With expertise in disease model customization, pathology research, drug development, and more, we offer comprehensive solutions to advance scientific discoveries.